| 标题 |
 An Open-label, Phase 2 Randomized Trial of Camrelizumab (SHR1210) Plus Apatinib Versus Paclitaxel and Cisplatin/Carboplatin Plus Bevacizumab as a First-line Therapy in Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer |
| 网址 | |
| DOI |
暂未提供，该求助的时间将会延长，查看原因？
|
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)
无极微光
吃葡萄不吐葡萄皮
极限001
秋风
aaaa
彭于彦祖
v0id
null
04d
lx
Maestro_S
风吹麦浪
YY
Criminology34
cdercder
初景
sufu_jony
牧青
七听
殷勤的紫槐
皖公网安备34019202002308
